Argus Research Maintains Buy on Corteva, Raises Price Target to $91

Benzinga Newsdesk www.benzinga.com Positive 72.2%

Neg 0% Neu 0% Pos 72.2%

Argus Research analyst Bill Selesky maintains Corteva (NYSE:CTVA) with a Buy and raises the price target from $80 to $91.